Events

Past events

Date	Event Details
Summary Toggle 06/28/17 12:00 PM EDT	Annual Ordinary Shareholders’ Meeting Supporting Materials Invitation to the ordinary shareholders’ meeting 58.3 KB 2016 Annual Report 4.3 MB AGM 2017 Presentation 2.9 MB
Summary Toggle 11/07/17 10:55 AM MST	Credit Suisse Healthcare Conference A webcast of the presentation will be available on the Investor Page of AC Immune's website and will be active for 90 days following the event. Click here for webcast Supporting Materials Credit Suisse Healthcare Conference 2.5 MB
Summary Toggle 11/15/17 8:40 AM GMT	Jefferies London Healthcare Conference A webcast of the presentation will be available on the Investor Page of AC Immune's website and will be active for 90 days following the event. Supporting Materials Jefferies London Healthcare Conference 2.5 MB
Summary Toggle 12/01/17 12:00 PM EST	AC Immune Key Opinion Leader (KOL) Luncheon Click here for webcast Location St. Regis Hotel New York, NY 10001 United States Supporting Materials Targeting Alzheimer’s and Other Neurodegenerative Diseases with Novel Therapeutics and Diagnostics 1.6 MB Anti-TAU Approaches 1.2 MB
Summary Toggle 02/15/18 at 10:30 AM EST	AC Immune SA at Leerink Partners Annual Global Healthcare Conference Click here for webcast Location Lotte New York Palace New York, NY 10001 United States Supporting Materials AC Immune Presentation - February 2018 3.5 MB
Summary Toggle 02/27/18 at 12:00 PM EST to 02/28/18 at 11:59 PM EST	AC Immune SA at Credit Suisse 2018 Global Healthcare Conference Location London, UK
Summary Toggle 03/15/18 - 03/18/18	AC Immune SA at the AAT-AD/PDTM Conference Location Torino, Italy
Summary Toggle 04/09/18 at 9:25 AM CEST	AC Immune SA at H.C. Wainwright Global Life Sciences Conference Click here for webcast Location Le Meridien Plaza Hotel Salon Atlantic W (2nd Floor) Monte Carlo, Monaco Monaco
Summary Toggle 04/27/18 at 12:00 PM CEST	Extraordinary Shareholders’ Meeting Supporting Materials Invitation to the Extraordinary Shareholders’ Meeting 4.3 MB Instructions on how to become a holder of record 277.9 KB
Summary Toggle 07/06/18 at 12:00 PM CEST	Annual Ordinary Shareholders’ Meeting Supporting Materials 2017 Annual Report 3.1 MB Invitation to the ordinary shareholders' meeting 7.4 MB AGM 2018 Presentation 1.3 MB
Summary Toggle 11/05/18 at 12:00 PM EST	AC Immune Key Opinion Leader (KOL) Luncheon - Abeta Oligomers and Concomitant Proteinopathies in Alzheimer’s Disease and Other Neurodegenerative Diseases Click here for webcast Location Nasdaq MarketSite 4 Times Square New York, NY 10001 United States
Summary Toggle 11/15/18 at 12:40 PM UTC	AC Immune SA at Jefferies 2018 London Healthcare Conference Click here for webcast
Summary Toggle 01/24/19 at 4:00 PM CET	Webcast: AC Immune CEO, Andrea Pfeifer, at World Economic Forum Click here for webcast
Summary Toggle 04/09/19 at 1:30 PM BST	AC Immune SA at H.C. Wainwright Global Life Sciences Conference Click here for webcast
Summary Toggle 06/28/19 at 11:30 AM CEST	Annual Ordinary Shareholders’ Meeting Supporting Materials 2018 Annual Report 11.6 MB Invitation to the ordinary shareholders’ meeting 8.1 MB Instructions on how to become a holder of record 131.4 KB AGM 2019 Presentation 2.1 MB
Summary Toggle 07/11/19 at 8:30 AM EDT	AC Immune Key Opinion Leader (KOL) Breakfast - Treating Alzheimer’s disease in people with Down syndrome Click here for webcast Location The Benjamin Hotel, New York City
Summary Toggle 11/06/19 at 12:00 PM EST	AC Immune Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative Diseases Click here for webcast Location New York City
Summary Toggle 11/21/19 at 5:20 PM GMT	AC Immune SA at Jefferies 2019 London Healthcare Conference Click here for webcast
Summary Toggle 05/20/20 at 3:10 PM CEST	AC Immune SA at UBS Virtual Global Healthcare Conference Click here for webcast
Summary Toggle 06/23/20 at 12:00 PM EDT	SVB Leerink Second Annual CNS Forum Webcast replay: Tutorial on Tau and the ACIU Approach Supporting Materials Targeting Tau in Neurodegenerative Disease 1.2 MB
Summary Toggle 06/26/20 at 11:00 AM CEST	Annual Ordinary Shareholders’ Meeting Supporting Materials Annual General Meeting 2020 Presentation 2.1 MB Meeting Minutes - Annual General Meeting 2020 4.3 MB 2019 Annual Report 5.3 MB
Summary Toggle 09/15/20 at 10:00 AM EDT	AC Immune SA at H. C. Wainwright 22nd Annual Global Investment Conference Click here for webcast
Summary Toggle 11/18/20 at 6:45 AM EST	AC Immune SA at Jefferies Virtual London Healthcare Conference Click here for webcast
Summary Toggle 11/20/20 at 2:00 PM CET	Extraordinary Shareholders' Meeting Supporting Materials Invitation to the extraordinary shareholders’ meeting 635.8 KB Proxy Card 29.3 KB Declaration of Honor 438.5 KB Official Invitation to EGM (published in Swiss Official Gazette of Commerce) 390.6 KB Official Invitation to EGM (published in Swiss Official Gazette of Commerce) Results of the EGM (Form 6-K) 150.6 KB
Summary Toggle 01/14/21	Global Be Brain Powerful BrainTrust Dialogues: Worldview Disclaimer: The views and opinions expressed during this presentation are those of the speakers alone and do not necessarily reflect the official policy or position of AC Immune SA. Webcast replay
Summary Toggle 01/25/21	World Economic Forum: Davos Dialogues - Tackling Today’s Silent Global Pandemic Featured Speakers: Margaret Chan, Formerly WHO, Haruo Naito, Eisai Co. Ltd, Andrea Pfeifer, AC Immune SA, and George Vradenburg, Davos Alzheimer’s Collaborative Disclaimer: The views and opinions expressed during this presentation are those of the speakers alone and do not necessarily reflect the official policy or position of AC Immune SA. Webcast replay
Summary Toggle 02/24/21 at 11:20 AM EST	SVB Leerink 10th Annual Global Healthcare Conference Click here for webcast
Summary Toggle 03/09/21 - 03/14/21	AD/PD™ 2021 Virtual Conference Visit the AD/PD™ 2021 Virtual Conference website to learn more. Scientific updates at AD/PDTM 2021 Morphomer™ TDP-43 imaging Title: Discovery of PET tracers for TDP-43 proteinopathies Date: Thursday, March 11, 2021 \| 10:45 – 11:00 am CET Presenter: Oral presentation by Tamara Seredenina Anti-TDP-43 antibody Title: TDP-43 antibody directed microglial clearance and inhibition of seeded aggregation mitigates neuropathology in models of TDP-43 proteinopathy Date: Thursday, March 11, 2021 \| 11:15 – 11:30 am CET Presenter: Oral presentation by Tariq Afroz Morphomer™ alpha-synuclein imaging Title: [18F]ACI-12589, a novel alpha-synuclein radiotracer as a biomarker in patients with Parkinson's disease and other synucleinopathies E-poster ID: P531 / #868 Presenter: E-poster presentation by Efthymia Vokali Morphomer™ alpha-synuclein small molecule aggregation inhibitor Title: Generating a first-in-class inhibitor to treat Parkinson's disease by targeting intracellular alpha-synuclein pathology E-poster ID: P425 / #1195 Presenter: E-poster presentation by Nadine Aït-Bouziad
Summary Toggle 03/16/21	2021 Global Down Syndrome Forum 2:00 – 6:00 PM CET / 9:00 AM – 1:00 PM ET Register and view the live event Supporting Materials Agenda 151.9 KB
Summary Toggle 03/31/21 at 2:00 PM CEST	Extraordinary Shareholders' Meeting Click here for more information
Summary Toggle 03/31/21 at 10:00 AM EDT	AC Immune’s Morphomer™ Small Molecule Technology Platform and Pipeline Click here for webcast Supporting Materials Morphomer™: Platform and Pipeline Review 5.3 MB

Events

Upcoming events

Past events

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials

Supporting Materials